| Literature DB >> 27235919 |
Anthony N Imudia1, Shayne Plosker2.
Abstract
Preimplantation genetic testing (PGT) of oocytes and embryos is the earliest form of prenatal testing. PGT requires in vitro fertilization for embryo creation. In the past 25 years, the use of PGT has increased dramatically. The indications of PGT include identification of embryos harboring single-gene disorders, chromosomal structural abnormalities, chromosomal numeric abnormalities, and mitochondrial disorders; gender selection; and identifying unaffected, HLA-matched embryos to permit the creation of a savior sibling. PGT is not without risks, limitations, or ethical controversies. This review discusses the techniques and clinical applications of different forms of PGT and the debate surrounding its associated uncertainty and expanded use.Entities:
Keywords: Aneuploidy; Embryo research; Preimplantation genetic diagnosis (PGD); Preimplantation genetic screening (PGS); Preimplantation genetic testing (PGT); Single-gene disorder
Mesh:
Year: 2016 PMID: 27235919 DOI: 10.1016/j.cll.2016.01.012
Source DB: PubMed Journal: Clin Lab Med ISSN: 0272-2712 Impact factor: 1.935